Posts Tagged ‘aaps’

The U.S. Department of Health and Human Services and FDA today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant milestone in the administration’s broader initiative to Make America Healthy Again. Source: FDA Press Releases

FDA Commissioner Martin A. Makary, M.D., M.P.H. announces a policy directive that limits individuals employed at companies regulated by the FDA from serving as official members on FDA advisory committees, where statutorily allowed Source: FDA Press Releases

The U.S. Food and Drug Administration today welcomed HHS Secretary Robert F. Kennedy, Jr. to its headquarters in Silver Spring, Maryland, a visit that included remarks to FDA employees, meetings with agency leadership, and a tour of several medical device innovation laboratories on the Campus Source: FDA Press Releases

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs Source: FDA Press Releases

Renowned surgeon-scientist and health policy expert, Martin A. Makary, M.D., M.P.H., took the oath of office to become the 27th Commissioner of Food and Drugs. Source: FDA Press Releases

Today, the U.S. Food and Drug Administration approved a novel treatment for hemophilia A or B, with or without factor VIII or IX inhibitors (neutralizing antibodies). Source: FDA Press Releases

FDA Roundup: March 28, 2025 Source: FDA Press Releases

The FDA granted marketing authorization of the first diagnostic test for chlamydia, gonorrhea and trichomoniasis that can be purchased without a prescription and performed entirely at home. Source: FDA Press Releases

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Source: FDA Press Releases

Under the leadership of HHS Secretary Robert F. Kennedy, Jr., the FDA unveiled a Chemical Contaminants Transparency Tool providing an online searchable database providing a consolidated list of contaminant levels (e.g., tolerances, action levels, and guidance levels) that are used to evaluate potent Source: FDA Press Releases